All PlansAdministrativeMedium impact
Voluntary nationwide recall: Vancomycin (Amneal - March)
UPMC Health Plan·Infectious Disease, Internal Medicine, Family Medicine +1 more·Pharmacy
Effective date
Mar 27, 2024
We identified it
Jun 20, 2026
Summary
Amneal Pharmaceuticals has issued a voluntary nationwide recall of four lots of Vancomycin Hydrochloride Oral Solution due to potential overfilling that could cause higher doses and adverse effects like kidney damage. Healthcare providers should stop using affected lots and return them to the place of purchase.
Action Required
Immediately: Clinical staff should identify patients who received Vancomycin Hydrochloride Oral Solution 250 mg/5 mL from Amneal and check if medication is from recalled lots. Contact affected patients to stop using the medication and return to pharmacy. Document any adverse events and report to FDA. Billing team should flag any recent claims for this specific medication for potential follow-up care billing.